Management of cutaneous B-cell lymphoma: Recommendations of the French cutaneous lymphoma study group;Prise en charge des lymphomes B cutanés : recommandations du Groupe français d'étude des lymphomes cutanés

Annales de Dermatologie et de Venereologie

Volumn 137, Issue 8-9, 2010, Pages 523-531

  Grange, F ^a   D'Incan, M ^b   Ortonne, N ^c   Dalac, S ^d   Laroche, L ^e   Beylot Barry, M ^f   Delfau Larue, M H ^c   Vergier, B ^f   Bagot, M ^g  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL DU BOCAGE   (France)

^e AVICENNE HOSPITAL   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

Cutaneous B cell lymphoma; Recommendations; Staging; Therapy

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; INTERFERON; RITUXIMAB;

B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; COMBINATION CHEMOTHERAPY; FRANCE; HUMAN; IMMUNOPATHOLOGY; LABORATORY TEST; MARGINAL ZONE LYMPHOMA; NOTE; RADIATION DOSE; SKIN LYMPHOMA;

EID: 77956267752     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2010.04.016     Document Type: Short Survey

References (38)

1. R. Willemze, E.S. Jaffe, G. Burg, L. Cerroni, E. Berti, and S.H. Swerdlow WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785
2. N. Senff, E.M. Noordijk, Y.H. Kim, M. Bagot, E. Berti, and L. Cerroni European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas Blood 112 2008 1600 1609
3. E. Bathelier, L. Thomas, B. Balme, B. Coiffier, G. Salles, and F. Berger Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone-B cell lymphoma Br J Dermatol 159 2008 498 500
4. N.J. Senff, H.C. Kluin-Nelemans, and R. Willemze Results of bone marrow aspiration in 275 patients with histologival features that suggest an indolent form of cutaneous B-cell lymphoma Br J Haematol 142 2008 152 156
5. P.H. Kuo, B.L. McClennan, K. Carlson, L.D. Wilson, R.L. Edelson, and P.W. Heald FDG-PET/CT in the evalutation of cutaneous T-cell lymphoma Mol Imaging Biol 10 2008 74 81
6. M. Santucci, N. Pimpinelli, and L. Arganini Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases Cancer 67 1991 2311 2326
7. J.J. Hoefnagel, M.H. Vermeer, P.M. Jansen, F. Heule, P.C. van Voorst Vader, and C.J. Sanders Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases Arch Dermatol 141 2005 1139 1145
8. F. Grange, M.W. Bekkenk, J. Wechsler, L. Cerroni, M. Bernengo, and C.J. Meijer Prognostic factors in primary cutaneous large B-cell lymphomas: a European Multicenter Study J Clin Oncol 19 2001 3602 3610
9. N.J. Senff, J.J. Hoefnagel, K.J. Neelis, M.H. Vermeer, E.M. Noordijk, and R. Willemze Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification Arch Dermatol 153 2007 1520 1526
10. B.D. Smith, E.J. Glusssac, J.M. McNiff, G.L. Smith, P.W. Heald, and D.L. Cooper Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the EORTC and the WHO classification systems J Clin Oncol 22 2004 634 639
11. M.W. Bekkenk, M.H. Vermeer, M.L. Geerts, E.M. Noordijk, F. Heule, and P.C. van Voorst Vader Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients J Clin Oncol 17 1999 2471 2478
12. P.L. Zinzani, P. Quaglino, N. Pimpinelli, E. Berti, G. Baliva, and S. Rupoli Prognostic factors in primary cutaneous B-cell lymphoma: the Italian study group for cutaneous lymphomas J Clin Oncol 24 2006 1376 1382
13. K.J. Neelis, E.C. Schimmel, M.H. Vermeer, N.J. Senff, R. Willemze, and E.M. Noordijk Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas Int J Radiat Oncol Biol Phys 74 2009 154 158
14. B. Kütting, G. Bonsmann, D. Metze, T.A. Luger, and L. Cerroni Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a J Am Acad Dermatol 36 1997 311 314
15. E. Roggero, E. Zucca, C. Mainetti, F. Bertoni, C. Valsangiacomo, and E. Pedrinis Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin Hum Pathol 31 2000 263 268
16. F. Grange, J. Wechsler, J.C. Guillaume, J. Tortel, B. Jauhlac, and M.C. Tortel Borrelia burgdorferi infection simulating a primary cutaneous B-cell lymphoma J Am Acad Dermatol 47 2002 530 534
17. Société de pathologie infectieuse de langue française 16th consensus conference on treatment of infectious diseases. Lyme disease (borreliosis) diagnostic approach, therapy and prevention Rev Neurol 163 2007 1273 1279
18. R. Fink-Puches, I.H. Wolf, I. Zalaudek, H. Kerl, and L. Cerroni Treatment of primary cutaneous B-cell lymphoma with rituximab J Am Acad Dermatol 52 2005 847 853
19. E. Gitelson, T. Al-Saleem, M. Millenson, S. Lessin, and M.R. Smith Cutaneous B-cell lymphoma responds to rituximab: a report of 5 cases and review of the literature Leuk Lymphoma 47 2006 1902 1907
20. M.C. Kyrtsonis, M.P. Siakantaris, C. Kalpadakis, M.N. Dimopoulou, T.P. Vassilakopoulos, and F.N. Kontopidou Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab Eur J Haematol 77 2006 300 303
21. K. Kerl, C. Prins, J.H. Saurat, and L.E. French Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of 8 cases Br J Dermatol 155 2006 1197 1200
22. S. Gellrich, J.M. Muche, A. Wilks, K.C. Jasch, C. Voit, and T. Fischer Systemic 8 cycles anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas. an applicational observation Br J Dermatol 153 2005 167 173
23. J. Valencak, F. Weihsengruber, K. Rappersberger, F. Trautinger, A. Chott, and B. Streubel Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients Ann Oncol 20 2009 326 330
24. T. Paul, P. Radny, Kröber, A. Paul, H.J. Blaheta, and C. Garbe Intralesional rituximab for cutaneous lymphoma Br J Dermatol 144 2001 1239 1243
25. A.V. Morales, R. Advani, S.M. Horwitz, N. Riaz, S. Reddy, and R.T. Hoppe Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab J Am Acad Dermatol 59 2008 953 957
26. S. Maza, S. Gellrich, C. Assaf, M. Beyer, L. Spilker, and H. Orawa Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre study Leuk Lymphoma 49 2008 1702 1709
27. F. Grange, M. Beylot-Barry, P. Courville, E. Maubec, M. Bagot, and B. Vergier Primary cutaneous large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases Arch Dermatol 143 2007 1144 1150
28. S. Pulini, S. Rupoli, G. Goteri, N. Pimpinelli, R. Alterini, and A. Bettacchi Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies Eur J Haematol 82 2009 184 193
29. B. Coiffier, E. Lepage, J. Brire, R. Herbrecht, H. Tilly, and R. Bouabdallah CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma N Eng J Med 346 2002 235 242
30. C. Thieblemont, and B. Coiffier Lymphoma in older patients J Clin Oncol 25 2007 1916 1923
31. F. Grange, E. Maubec, M. Bagot, M. Beylot-Barry, P. Joly, and S. Dalle Treatment of primary cutaneous diffuse large B-cell lymphomas, leg type, with age-adapted combinations of chemotherapies and rituximab Arch Dermatol 145 2009 329 330
32. M.H. Vermeer, F.A.M.J. Geelen, C.W. van Haselen, P.C. van Voorst Vader, M.L. Geerts, and W.A. van Vloten Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis Arch Dermatol 132 1996 1304 1308
33. K. Kodama, C. Massone, A. Chott, D. Metze, H. Kerl, and L. Cerroni Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients Blood 106 2005 2491 2497
34. F. Grange, and M. Bagot Pronostic des lymphomes B cutanés primitifs Ann Dermatol Venereol 129 2002 30 40
35. N.J. Senff, and R. Willemze The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphoma other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group Br J Dermatol 157 2007 1205 1211
36. Y.H. Kim, R. Willemze, N. Pimpinelli, S. Whittaker, E.A. Olsen, and A. Ranki TNM classification for primary cutaneous lymphomas other than MF/SS: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC) Blood 110 2007 479 484
37. N.J. Senff, J.J. Hoefnagel, P.M. Jansen, M.H. Vermeer, J. van Baarlen, and W.A. Blokx Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers J Clin Oncol 25 2007 1581 1587
38. A. Guyot, N. Ortonne, L. Valeyrie-Allanore, and M. Bagot Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients Arch Dermatol 146 2010 89 91